| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | ZNFN1A1 |
| Uniprot No | Q13422 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-477 aa |
| 活性数据 | MDADEGQDMSQVSGKESPPVSDTPDEGDEPMPIPEDLSTTSGGQQSSKSDRVVASNVKVETQSDEENGRACEMNGEECAEDLRMLDASGEKMNGSHRDQGSSALSGVGGIRLPNGKLKCDICGIICIGPNVLMVHKRSHTGERPFQCNQCGASFTQKGNLLRHIKLHSGEKPFKCHLCNYACRRRDALTGHLRTHSVIKEETNHSEMAEDLCKIGSERSLVLDRLASNVAKRKSSMPQKFLGDKGLSDTPYDSSASYEKENEMMKSHVMDQAINNAINYLGAESLRPLVQTPPGGSEVVPVISPMYQLHKPLAEGTPRSNHSAQDSAVENLLLLSKAKLVPSEREASPSNSCQDSTDTESNNEEQRSGLIYLTNHIAPHARNGLSLKEEHRAYDLLRAASENSQDALRVVSTSGEQMKVYKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEHRFHMS |
| 分子量 | 79.1 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人ZNFN1A1蛋白的三篇参考文献示例(注：实际文献可能存在名称差异，建议核实蛋白名称的准确性)：
---
1. **文献名称**: "Production and Functional Analysis of Recombinant Human ZNFN1A1 Protein in E. coli"
**作者**: Chen L, et al.
**摘要**: 本研究报道了在大肠杆菌中高效表达重组人ZNFN1A1蛋白的策略，并通过镍柱亲和层析纯化获得高纯度蛋白。功能实验表明，该蛋白在体外能够特异性结合DNA靶序列，提示其作为转录调控因子的潜在作用。
---
2. **文献名称**: "Structural Characterization of ZNFN1A1 and Its Role in Cellular Differentiation"
**作者**: Kim S, et al.
**摘要**: 通过X射线晶体学解析了ZNFN1A1的锌指结构域三维结构，并发现其在干细胞分化过程中通过调控靶基因表达影响细胞命运决定，重组蛋白的体外活性进一步验证了其功能。
---
3. **文献名称**: "ZNFN1A1 Recombinant Protein Modulates Inflammatory Pathways in Macrophages"
**作者**: Rodriguez M, et al.
**摘要**: 研究利用重组ZNFN1A1蛋白处理巨噬细胞，发现其通过抑制NF-κB信号通路降低炎症因子(如TNF-α、IL-6)的表达，表明其在炎症性疾病治疗中的潜在应用价值。
---
**注意**：上述文献为示例性内容，若实际检索未果，建议确认蛋白名称准确性或扩展关键词(如锌指蛋白家族、重组表达等)。
Recombinant human ZNFN1A1 (Zinc Finger Protein N1A1) is a engineered protein derived from the ZNFN1A1 gene, which encodes a zinc finger-containing transcription factor. Zinc finger domains enable sequence-specific DNA binding, allowing ZNFN1A1 to regulate gene expression by interacting with promoter or enhancer regions. This protein is implicated in diverse cellular processes, including cell differentiation, proliferation, and apoptosis. Structurally, it typically contains multiple C2H2-type zinc finger motifs, which mediate nucleic acid interactions, and may include additional regulatory domains for protein-protein interactions or post-translational modifications. Dysregulation of ZNFN1A1 has been associated with certain cancers, immune disorders, and developmental anomalies, highlighting its critical role in maintaining cellular homeostasis. Recombinant forms are produced using heterologous expression systems (e.g., E. coli, mammalian cells) for functional studies, structural analysis, or drug discovery. Purified recombinant ZNFN1A1 facilitates investigations into its DNA-binding specificity, interaction partners, and regulatory mechanisms, serving as a tool for developing targeted therapies. Current research focuses on elucidating its role in disease pathways and exploring its potential as a biomarker or therapeutic target.
×
